I now have everything needed for a comprehensive answer on hair loss (alopecia).
Hair Loss (Alopecia)
Alopecia is the medical term for hair loss. The two major categories are scarring (permanent) and non-scarring (potentially reversible), depending on whether hair follicles are destroyed.
Classification Overview
| Type | Follicles | Reversible? | Examples |
|---|
| Non-scarring | Preserved | Yes | Androgenetic alopecia, alopecia areata, telogen effluvium, tinea capitis |
| Scarring (cicatricial) | Destroyed | No | Discoid lupus, lichen planopilaris, folliculitis decalvans, central centrifugal cicatricial alopecia |
In non-scarring alopecia, hair shafts are absent or miniaturized but follicles are preserved - explaining why regrowth is possible. In scarring alopecia, fibrosis and inflammation permanently destroy follicular openings. - Harrison's Principles of Internal Medicine 22E
1. Androgenetic Alopecia (Pattern Hair Loss)
The most common form in both men and women.
Male Pattern
- Begins in teens, 20s, or early 30s; starts with bitemporal recession ("professor angles") and vertex thinning
- Driven by dihydrotestosterone (DHT) - 5α-reductase converts testosterone to DHT, which miniaturizes follicles
- Each hair cycle produces finer, shorter hairs; terminal hairs are replaced by vellus hairs
- Progressive shortening of anagen phase; parietal and occipital areas typically spared
Female Pattern
- Diffuse thinning throughout the apical scalp; frontal hairline usually preserved
- Same follicular miniaturization and DHT mechanism as males, though less pronounced
- Always consider underlying androgen excess (PCOS, ovarian/adrenal tumor) if signs of virilization exist
Pathogenesis
- Polygenic inheritance with androgen sensitivity
- Higher 5α-reductase and androgen receptor levels in frontal vs. occipital follicles
- Androgen-inducible TGF-β1 from dermal papilla cells suppresses hair growth
- Eunuchs do not develop baldness - confirms androgen dependence
Treatment
| Drug | Mechanism | Key Facts |
|---|
| Minoxidil (topical 2%/5%) | Prolongs anagen, enlarges shaft diameter, promotes dermal papilla cell survival | Best for early cases (<10 yr), bald area <10 cm; must use indefinitely |
| Finasteride (1 mg/day, oral) | Type 2 5α-reductase inhibitor; blocks DHT production | Stops hair loss in ~90% of men; 65% show regrowth; takes ≥6 months; not for women of childbearing age |
| Dutasteride | Blocks both type 1 & type 2 5α-reductase | More complete DHT suppression than finasteride |
| Hair transplantation | Micrografts from occipital to frontal scalp | Excellent cosmetic results; occipital follicles are DHT-resistant |
- Andrews' Diseases of the Skin, pp. 871-872
2. Alopecia Areata (AA)
An autoimmune, non-scarring hair disorder affecting all ages and both sexes equally.
Variants
- Patchy AA - circumscribed patches (most common)
- Alopecia totalis - complete loss of scalp hair
- Alopecia universalis - complete loss of all body hair
Pathogenesis
- Loss of immune privilege of the hair follicle - normally, follicles express low MHC Class I/II and produce local immunosuppressive cytokines
- CD8+ cytotoxic T cells (supported by IL-15 and IFN-γ) attack anagen hair bulbs, inducing premature catagen transition
- Since only the bulb is attacked (not the stem cell-containing bulge), regrowth is possible - classic non-scarring pattern
- Associated with other autoimmune diseases: thyroiditis, vitiligo, atopic dermatitis
- Fitzpatrick's Dermatology, p. 229
Clinical Features
- Well-demarcated, smooth, circular bald patches
- "Exclamation mark hairs" - broken, tapered hairs at patch margin
- Scalp biopsy: lymphocyte-predominant inflammation around anagen bulbs
Treatment
- Intralesional corticosteroids (triamcinolone acetonide) - first-line for limited disease
- Topical/systemic corticosteroids - for more extensive disease
- JAK inhibitors (baricitinib, ritlecitinib) - FDA-approved for severe AA; block JAK-STAT signaling, suppress inflammatory T cells, and directly promote hair follicle growth
- Topical minoxidil (adjunct)
- Spontaneous regrowth occurs in ~50% of patchy AA cases
3. Telogen Effluvium (TE)
The most common cause of diffuse hair loss. - Fitzpatrick's Dermatology
Mechanism
- Premature termination of the anagen (growth) phase of hair follicles → increased proportion in telogen (rest) phase → excessive shedding of club hairs (hairs with depigmented, club-shaped bulb, no sheath)
- Hair loss typically occurs 2-4 months after the triggering event
Common Triggers
- Fever / systemic illness
- Childbirth (postpartum effluvium) - most common type in women
- Major surgery or trauma
- Emotional stress
- Rapid weight loss / crash dieting
- Iron deficiency
- Hypothyroidism / hyperthyroidism
- Drugs (heparin, warfarin, propylthiouracil, isotretinoin, lithium, beta-blockers, interferons, colchicine, amphetamines)
- Chemotherapy (anagen effluvium - even more abrupt)
Types
| Subtype | Features |
|---|
| Acute TE | Classic; follows a known trigger; self-limiting |
| Chronic diffuse telogen hair loss | Multiple recurring triggers; no single identifiable cause |
| Chronic TE | Unknown etiology; mostly middle-aged women; whole-scalp involvement |
Diagnosis
- Pull test: grasp 40 hairs, slow pull - >4-6 club hairs is abnormal
- Shed hairs show depigmented club-shaped bulb (vs. anagen hairs which have pigmented bulb + sheath)
- Normal scalp has ~100,000 hairs; normal daily loss 100-150; in TE, 150-400+ shed daily
Treatment
- Identify and remove the trigger - spontaneous recovery is expected in most acute cases
- No specific therapy usually required; full recovery once the cause is corrected
- Andrews' Diseases of the Skin, p. 870
4. Scarring Alopecias
| Condition | Key Features |
|---|
| Discoid lupus erythematosus | Erythematous scaly plaques; hypopigmented center, hyperpigmented rim |
| Lichen planopilaris | Violaceous perifollicular macules at periphery of patches |
| Folliculitis decalvans | Follicular pustules at periphery; can cause reactive arthritis |
| Central centrifugal cicatricial alopecia | Most common scarring alopecia in Black women; starts at vertex |
| Linear scleroderma (morphea) | Band of sclerosis along scalp |
Active inflammation is at the periphery; fibrosis and follicular destruction is at the center. Biopsy + direct immunofluorescence is needed to differentiate these conditions.
5. Other Causes of Hair Loss
| Cause | Pattern | Notes |
|---|
| Tinea capitis | Patchy with scaling | Fungal; treated with systemic antifungals |
| Secondary syphilis | "Moth-eaten" scattered patches | Serologic testing |
| Traction alopecia | Marginal/frontal | From tight hairstyles; early cases are reversible |
| Alopecia mucinosa | Follicular papules with mucin | May be associated with lymphoma |
| Hypothyroidism/hyperthyroidism | Diffuse thinning | Reversible with treatment |
| SLE (non-scarring form) | Frontal "lupus hairs" | Coincides with disease flares |
| Pressure alopecia | Localized | From prolonged pressure (surgery, ICU) |
Diagnostic Approach Summary
- Scarring vs. non-scarring - look for follicular openings on scalp
- Pattern - diffuse vs. patchy vs. patterned
- Pull test - assess telogen shed
- History - triggering events 2-4 months prior, medications, systemic symptoms
- Labs - TSH, ferritin, CBC, androgens (in women with virilization)
- Scalp biopsy - gold standard for scarring alopecias and diagnostic uncertainty
- Dermoscopy/trichoscopy - non-invasive assessment of follicular miniaturization, exclamation mark hairs, etc.
Sources: Harrison's Principles of Internal Medicine 22E, p. 2070-2082 | Fitzpatrick's Dermatology 9e, pp. 229-234 | Andrews' Diseases of the Skin, pp. 869-873